<DOC>
	<DOCNO>NCT01157312</DOCNO>
	<brief_summary>The purpose study compare determine efficacy minimal stimulation clomiphene citrate ( CC ) first-line treatment infertile woman Polycystic Ovary Syndrome ( PCOS ) .</brief_summary>
	<brief_title>Minimal Stimulation Clomiphene Citrate Treatment Polycystic Ovary Syndrome</brief_title>
	<detailed_description>All patient receive 100 mg CC ( ClomidÂ® ; Global Napi Pharmaceuticals , Cairo , Egypt ) 5 day start day 3 spontaneous induce menstruation . In group A ( minimal stimulation ) , 2 vial highly purified uFSH , 150 IU ( Fostimon ; IBSA , Lugano , Switzerland , 75 IU/vial ) give IM cycle day 9 . A total 3 cycle offer group .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>PCOS No infertility factor No previous use ovarian stimulation drug Congenital adrenal hyperplasia Cushing syndrome Androgen secreting tumor</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Polycystic ovary syndrome</keyword>
	<keyword>clomiphene citrate</keyword>
	<keyword>minimal stimulation</keyword>
	<keyword>infertility treatment</keyword>
</DOC>